November 3, 2025 November 3, 2025Categories Ongoing TrialsOngoing Trials: A closer look at ECOG-ACRIN’s clinical trials for patients with pancreatic conditionsFor Pancreatic Cancer Awareness Month, we highlight two actively recruiting clinical trials for patients with pancreatic conditions
July 24, 2025 July 24, 2025Categories Trial ResultsTrial Results: ECOG-ACRIN research round-up – Summer 2025Takeaways from ECOG-ACRIN trials presented at the 2025 American Society of Clinical Oncology Annual Meeting
July 2, 2024 July 2, 2024Categories New TrialsNow Enrolling: This myeloMATCH trial is testing a new treatment for patients with acute myeloid leukemia that has a FLT3-ITD or D835 mutationThis study compares a standard initial treatment with a new approach that has the potential to put more patients into remission
March 26, 2024 March 26, 2024Categories New TrialsNow Enrolling: ComboMATCH treatment trial E5 is testing a new option for patients with advanced solid tumors that have a KRAS G12C mutationThis study is assessing the combination of two drugs—sotorasib and panitumumab—in patients with KRAS G12C-mutated solid tumors